Clinical Trial Update: Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing GIK2 to standard GIK therapy in acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• GIK (glucose insulin potassium therapy)
• GIK2

Snippet

Sponsor: University of Monastir | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED